Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2008
10/22/2008EP1982192A1 METHOD FOR ProNGF ASSAY FOR IN VITRO DIAGNOSIS OF CANCER IN PARTICULAR BREAST , THYROID AND LUNG CANCER AND THERAPEUTIC USE OF ProNGF
10/22/2008EP1982190A2 Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents
10/22/2008EP1981981A1 Anti-met monoclonal antibody, fragments and vectors thereof, for the treatment of tumors and corresponding products
10/22/2008EP1981964A2 Mycobacterial seca2 mutants
10/22/2008EP1981913A2 Antibodies that bind par-2
10/22/2008EP1981911A2 Synergistic compositions for treating hiv
10/22/2008EP1981540A2 Method of treatment and prophylaxis of diseases related to amyloid deposition using igm
10/22/2008EP1981538A2 Metalloproteinase binding proteins
10/22/2008EP1981537A2 Activation of hcv-specific t cells
10/22/2008EP1981536A1 Colonization factor (cf) antigens of enterotoxigenic escherichia coli in recombinant bacteria
10/22/2008EP1981535A2 Compositions and methods of modulating the immune response
10/22/2008EP1981533A1 Vaccine and antigen mimotopes against cancerous diseases associated with the carcinoembryonic antigen cea
10/22/2008EP1981532A2 Epha2 bite molecules and uses thereof
10/22/2008EP1981522A2 Compositions and methods for enhancing neuronal plasticity and regeneration
10/22/2008EP1981520A2 Combination therapy for the treatment of neovascular disorders
10/22/2008EP1857117A4 Agent for stimulating the production of a blood coagulation factor viii
10/22/2008EP1677823B1 Botulinum toxin treatments of neurological and neuropsychiatric disorders
10/22/2008EP1552848B1 Compositions against chicken coccidiosis
10/22/2008EP1532177B1 Immunomodulatory constructs and their uses
10/22/2008EP1375518B1 Anti-osteopontin antibody and use thereof
10/22/2008EP1368371B1 Transfection complexes
10/22/2008EP1311679B1 Method for inhibiting il-22 induced pap1
10/22/2008EP1307565B1 Vaccins against marek's disease virus (mdv) and varicella zoster virus (vzv)
10/22/2008EP1235590B1 A method of treating a malignancy in a subject and a pharmaceutical composition for use in same
10/22/2008EP1041888B1 Anti-retroviral immunogens, preparation and use
10/22/2008EP1017725B1 Method of affinity cross-linking biologically active, immunogenic peptides to antibodies
10/22/2008EP0854729B2 Improved methods for the production of non-covalently complexed and multivalent proteosome sub-unit vaccines
10/22/2008CN101292042A Cancerous desease modifying antibodies
10/22/2008CN101292041A Cancerous desease modifying antibodies
10/22/2008CN101291954A Modified antigen binding molecules with altered cell signaling activity
10/22/2008CN101291693A Novel use of il-1beta compounds
10/22/2008CN101291692A Anti-addl monoclonal antibody and use thereof
10/22/2008CN101291691A Immunogenic HIV compositions and related methods
10/22/2008CN101291690A Rotavirus vaccine inducing heterotypic cross protection
10/22/2008CN101291689A Vaccine stabilizing preparation of active antigen for large-scale inoculation system
10/22/2008CN101291688A A lentiviral vector-based vaccine
10/22/2008CN101291687A P53 vaccines for the treatment of cancers
10/22/2008CN101291675A Novel anticancer concomitant drug
10/22/2008CN101291579A Plant produced vaccine for amebiasis
10/22/2008CN101289658A Recombination virus particles for expressing 2-typed porcine circovirus nucleocapsid protein Cap gene
10/22/2008CN101289657A Recombination porcine parvovirus VP2 virus particles for expressing exogenous gene
10/22/2008CN101289511A Multivalent antibodies and uses therefore
10/22/2008CN101289510A Anti-CD40 monoclonal antibody
10/22/2008CN101289496A Epitope screening method capable of exciting anti-mycobacterium tuberculosis protective immunological reaction of body and uses
10/22/2008CN101288773A Complex type transgene lung cancer general tumor vaccine
10/22/2008CN101288771A Preparation method of anti-human Nogo-66 receptor protein vaccine and application thereof
10/22/2008CN101288770A New herpes simplex virus type II DNA vaccine
10/22/2008CN100427504C TNF alpha high-affinity chimeric antibody and use thereof
10/21/2008US7439349 Method for preparation of large volume batches of poly-ICLC with increased biological potency; therapeutic, clinical and veterinary uses thereof
10/21/2008US7439347 Hepatitis C virus non-structural NS3/4A fusion gene
10/21/2008US7439342 Thrombopoietin mimetics
10/21/2008US7439333 Vascular endothelial growth factor 2
10/21/2008US7439331 Inhibition of complement activation
10/21/2008US7439324 amyotrophic lateral sclerosis-specific epitope is conjugated to keyhole limpet hemocyanin; biodrug for eliciting immune response in animal to produce antibody; use in diagnosis, prognosis and therapeutic intervention in neurodegenerative Alzheimer's disease, Parkinson's disease, Huntington's disease
10/21/2008US7439321 Peptides for detection of antibody to Anaplasma phagocytophilum
10/21/2008US7439320 Cripto tumour polypeptide
10/21/2008US7439233 Vaccine for house dust mite allergen using naked DNA
10/21/2008US7439230 Extracellular domain of CTLA4, with (a) an alanine at position +29 substituted with tyrosine, leucine, tryptophan, or threonine, and (b) a leucine at position +104 substituted with glutamic acid; binds CD80 and/or CD86 with greater avidity; inhibiting graft versus host disease
10/21/2008US7439229 Controlling the action of cytokines, particularly chemokines, by inhibiting their binding with receptors; used as immunogens for use as metazoan parasite vaccines; antiallergens; veterinary medicine
10/21/2008US7439058 For use in vaccines
10/21/2008US7439053 Modified wild strain of enteroinvasive Shigella; cannot spread within and from infected cells to uninfected cells; vaccines; deactivation by inserting transposon into gene; does not disrupt capillaries in intestinal mucosa or release erythrocytes; mutagenizing; genetically engineered by allelic exchange
10/21/2008US7439052 Exposing human- or simian immunodeficiency virus to a delipidation process comprising solvent extraction using diisopropyl ether and/or 1-butanol to decrease lipid or cholesterol content of a viral envelope; vaccines; immunostimulants
10/21/2008US7439041 Prion-specific peptide reagents
10/21/2008US7438922 Allogeneic immunotherapy agent for cancer therapy; vaccine
10/21/2008US7438921 Buttock deformity treatment
10/21/2008US7438920 Crystallizable mixture and complexed crystal of hepatitis C virus NS3 helicase and a single stranded deoxyuridine oligonucleotide having 6 to 12 nucleotides; for use in X-ray crystallography; binding pocket structure
10/21/2008US7438919 An isolated protein; vaccines
10/21/2008US7438918 Lipid A deficient mutants of Neisseria meningitidis
10/21/2008US7438917 Peptide sequences specific for the hepatic stages of P. falciparum bearing epitopes capable of stimulating the T lymphocytes
10/21/2008US7438916 Therapeutic target for protozoal diseases
10/21/2008US7438915 Immunopotentiating effect of a Fomitella fraxinea-derived lectin on chicken immunity and resistance to coccidiosis
10/21/2008US7438914 Composition and method for enhancing immune response
10/21/2008US7438912 isolated hyperimmune serum-reactive antigen fragment; and an immunostimulant; nucleic acid molecule isolated from a S. agalactiae genomic DNA; Group B Streptococci
10/21/2008US7438911 Antibody against human insulin-like growth factor
10/21/2008US7438910 Quantitative analysis of interleukins in sample using monoclonal antibodies; antiinflammatory agents; antiarthritic agents
10/21/2008US7438909 Using monoclonal antibody to vaccinate mammals against anthrax toxin
10/21/2008US7438908 Antitumor agents
10/21/2008US7438907 and inhibits IL-2 binding to CD25; can be produced by a hybridoma, a transfectoma or in a nonhuman transgenic animal; treating diseases including organ, tissue and cell transplant rejection, autoimmune diseases, inflammatory and hyperproliferative skin disorders, and lymphoid neoplasms
10/21/2008US7438906 Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics
10/21/2008US7438905 administering a mixture of carriers and drugs that modulate signal transduction mediated by activation inducible lymphocyte immunomodulatory molecule (AILIM); immunosuppressants
10/21/2008US7438902 treating diabetes mellitus; isolating a nestin-positive pancreatic stem cell from a pancreatic islet of a donor; transferring the stem cell into the patient, wherein it differentiates into an insulin-producing cell; across allogeneic or xenogeneic barriers and graft rejection does not occur
10/21/2008CA2495581C Specific peptidic sequences of p. falciparum heptatic stages that carry epitopes capable of stimulating t lymphocytes
10/21/2008CA2387383C Use of anti-ferritin monoclonal antibodies in the treatment of some cancers
10/21/2008CA2289776C An infectious clone for human parainfluenza virus type 3
10/21/2008CA2230452C Novel 3' terminal sequence of hepatitis c virus genome and diagnostic and therapeutic uses thereof
10/21/2008CA2220226C Improved methods for transfecting t cells
10/21/2008CA2042064C C-erbb-2 external domain:gp75
10/16/2008WO2008124842A1 Treatments with helminths
10/16/2008WO2008124654A1 Methods for decreasing immune response and treating immune conditions
10/16/2008WO2008124647A2 Immunogenic compositions comprising mycobacterium tuberculosis polypeptides and fusions thereof
10/16/2008WO2008124646A2 Use of amyloid proteins as vaccine scaffolds
10/16/2008WO2008124483A1 Protein cage immunotherapeutics
10/16/2008WO2008124176A2 Soluble and membrane-anchored forms of lassa virus subunit proteins
10/16/2008WO2008124170A2 SELECTION OF HUMAN TNFα SPECIFIC ANTIBODIES
10/16/2008WO2008124109A2 System for pulling out regulatory elements using yeast
10/16/2008WO2008124055A1 Non-specific delayed-type hypersensitivity response to treat herpes simplex virus infection
10/16/2008WO2008123999A2 Anti-ige antibodies
10/16/2008WO2008123625A1 Method for activating receptor by cofactor and method for utilizing ligand activity
10/16/2008WO2008122817A2 Immunogenic compositions
10/16/2008WO2008122811A2 Adenoviral vectors encoding a pathogen or tumour antigen
1 ... 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 ... 1823